Flyer

Annals of Clinical and Laboratory Research

  • ISSN: 2386-5180
  • Journal h-index: 19
  • Journal CiteScore: 5.42
  • Journal Impact Factor: 4.64
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
+44 7460731551
Awards Nomination
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Directory of Research Journal Indexing (DRJI)
  • Publons
  • Euro Pub
  • Google Scholar
  • SHERPA ROMEO
  • Secret Search Engine Labs
  • Zenodo
Share This Page

Abstract

Immunopathogenesis and co-morbidities of Tuberculosis

Paul Timothy*

The etiologic agent of Tuberculosis (TB), Mycobacterium tuberculosis, continues to pose a serious threat to worldwide public health. Globally, 10.4 million new TB cases were recorded in 2016, and there were around 1.7 million TBrelated fatalities. One of the most important aspects of attempts to eliminate TB through the creation of potent vaccines and immunological treatments understands the host response to M. tuberculosis infection. An intracellular infection called M. tuberculosis spreads by the inhalation of aerosolized droplets carrying germs. The lungs' innate immune cells, particularly macrophages, dendritic cells, monocytes, and neutrophils, constitute the first line of defence against M. tuberculosis.

Published Date: 2023-01-28; Received Date: 2023-01-03